« SUMER & まさか交流戦 2nd | メイン | 木星接近！？ »
February 28, 2005
DBL最強王決定戦を考えてみる（ただの夢想です＾＾；）
いつもにこにこかどです。こんばんは。
既にご存知かと思いますが、私はダーツブログ連盟（略：DBL）という団体？に所属しています。
これは、ダーツブログを書いているダーツジャンキー達（人の事言えねぇーｗ）が集い、ダーツ仲間の輪を広げようと Ryu-Co. さんが創設されました。
創設して数ヶ月が過ぎ、メンバーも１００人以上！とかなり大規模になってきましたが、最近とみに思うことがあります。。。
そう、みんなダーツブログを書いてるんだから、ダーツが好き！じゃー誰が一番強いのか！？
ということで、実現の可否はともかくとして、DBL最強決定戦をやるとしたら？ということを思いつくままに書いて行こうかとおもいます。
ちなみに、絵空事ですので、クレームは一切受け付けません。（ｗ
■会場は？
DBLのメンバーは全国各地にいらっしゃいます。なので一番問題となるのは、開催する場所だと思います。
なので、思い切って、会場は全国数箇所に設けてしまえば良いと。（ｗ
例えば、福岡で九州地区。広島で中・四国地区。大阪で関西地区。愛知で中部地区。東京で関東地区という感じですね。もちろん関東は人が多いので複数の会場が必要になるかもしれませんが・・・。
あと、会場には人数で貸しきれる程度の、ネット環境が借りられる店が望ましいかな？
同日同時刻で、各地区の会場間を、Webカメラと音声チャットでつないで、地区間の交流と試合状況をわかりやすくするってのも良いかも。
■対戦方法は？
まず各地区で予選を実施して、地区代表を選出する。（試合形式は総当戦かな？）
各地区代表同士で、決勝トーナメントを行う。
もちろん、他地区代表との対戦になるので、擬似ネット対戦をする必要がある。そこは、もう原始的に筐体に二人分のお金を入れて、対戦モードにし、相手が当てた場所を手で押していく。(笑
もちろん自分以外の対戦費用はエントリーフィーでまかなう。
会場を移していたWebカメラで代表者を写し、筐体の音声を音声チャットで拾えばより臨場感がでるかも。。。
こんな大会を１年に１回開けたら・・・、メンバー同士の格好の交流の場になるような気もしますね。（＾＾ｖ
まぁ、DARTSLIVE か D-1 で早くネット対戦できるようになれば良いんですけどね。（ｗ ＜そうすれば万事解決。
ってことで、ただの夢物語ですよ。（＾＾
投稿者 kado_t_spt : February 28, 2005 11:39 PM
トラックバック
このエントリーのトラックバックURL:
http://blog.himawari-dream.com/mt-tb.cgi/179
このリストは、次のエントリーを参照しています: DBL最強王決定戦を考えてみる（ただの夢想です＾＾；）:
» http://mortages.forumlivre.com from mortages
the best mortages on the web [続きを読む]
トラックバック時刻: July 14, 2007 09:50 PM
コメント
関東・・・圧倒的に人数多いから、
予選会・・・大変そうだわｗ
でも楽しそう・・・・DBLのトーナメント・・・
続々と登場するblog記事・・・
吹き荒れるトラックバックの嵐・・・ｗ
たのしそーｗ
投稿者 みや＠ぶるろけ : March 1, 2005 01:18 AM
＞みやさん
たのしそーですよね？（ｗ
誰かリアルタイムでblog記事を書いたりすれば、来れなかった人にもわかるし（ｗ
てか、参加者５０名と考えて、その半数で記事をトラックバックしても２５名！ほんまに嵐だ（ｗ
投稿者 kado : March 1, 2005 12:23 PM
はじめまして、おなじくDBLにいれてもらっているちゅんこといいます。
いや〜、ほんとにできれば楽しそうな企画ですよね＾＾
私は選ばれないでしょうが、ダーツライブのrateのベスト１６でなんちゃってburnのようなランダムダブルスとかも面白いかと。
どんな形でもよいから実現されればいいですね〜
投稿者 ちゅんこ : March 1, 2005 02:08 PM
| |_・) チラリ!
ﾌﾑﾌﾑ･･･φ(・・。)ゞ
投稿者 Ryu-Co. : March 1, 2005 03:26 PM
＞ちゅんこさん
はじめまして！
そうなんですよ。今はまだ各地区で盛り上がってますが、ＤＢＬ全体で盛り上がるようなイベントがあれば、地区の壁を超えて交流が図れるかな？と思います！（＾＾
＞Ryu-Co.さん
その反応はナニ？＾＾；；
書き込みがあった事はメッセですぐにわかるんで、思わず即効で、突っ込みを入れたくなってしまいました。（ｗ
投稿者 kado : March 1, 2005 03:30 PM
いや〜みなさんの意見を参考にしようと思ってさぁ･･･
¢( ・_・) メモってんのさ！
投稿者 Ryu-Co. : March 1, 2005 03:49 PM
＞Ryu-Co.さん
今の所夢物語ですよ！こんなんできたらいいなーっていう。
でも、将来的にいつかやってみたいですね。＾＾／
投稿者 kado : March 1, 2005 03:56 PM
Good site. Thanks:-)
http://search10site.info Tour de France
投稿者 Tour de France : January 25, 2007 05:01 AM
Good site. Thanks!!!
http://theautocompany.info/ Mitsubishi Motors
投稿者 Mitsubishi Motors : January 25, 2007 08:20 AM
Cool site. Thank you:-)
http://themedcompany.info/ Health Insurance and Medica
投稿者 Health Insurance and Medica : January 25, 2007 09:30 AM
Nice site. Thanks!!!
http://ford-pickup-truck.msn.tn.uz/ ford pickup truck
投稿者 ford pickup truck : January 25, 2007 10:46 PM
Nice site. Thank you.
http://classic-ford-pickup.msn.tn.uz/ classic ford pickup
投稿者 classic ford pickup : January 26, 2007 04:47 AM
Nice site. Thank you:-)
http://ford-pickup.msn.tn.uz/vintage_ford_pickup_truck.html vintage ford pickup truck
投稿者 vintage ford pickup truck : January 26, 2007 03:14 PM
Very good site. Thanks!!!
http://ford-pickup-restore.msn.tn.uz/ ford pickup restore
投稿者 ford pickup restore : January 26, 2007 04:26 PM
Very good site. Thanks:-)
http://ford-pickup-restore.msn.tn.uz/vintage_ford_pickup_truck.html vintage ford pickup truck
投稿者 vintage ford pickup truck : January 26, 2007 08:15 PM
Nice site. Thanks!
http://ford-pickup-sale.msn.tn.uz/ ford pickup sale
投稿者 ford pickup sale : January 26, 2007 09:10 PM
Nice site. Thank you:-)
http://ford-old-pickup.msn.tn.uz/ ford old pickup
投稿者 ford old pickup : January 27, 2007 03:00 AM
Very good site. Thanks!!!
http://ford-model-pickup.msn.tn.uz/ ford model pickup
投稿者 ford model pickup : January 27, 2007 08:26 AM
Very good site. Thanks!!!
http://ford-model-pickup.msn.tn.uz/ ford model pickup
投稿者 ford model pickup : January 27, 2007 08:27 AM
Cool site. Thank you:-)
http://econoline-ford-pickup.msn.tn.uz/ econoline ford pickup
投稿者 econoline ford pickup : January 27, 2007 01:33 PM
Very good site. Thank you!
http://old-ford-pickup.msn.tn.uz/ old ford pickup
投稿者 old ford pickup : January 27, 2007 06:14 PM
Nice site. Thanks:-)
http://bed-ford-pickup.msn.tn.uz/ bed ford pickup
投稿者 bed ford pickup : January 27, 2007 11:20 PM
Good site. Thank you!
http://ford-pickup-part.msn.tn.uz/ ford pickup part
投稿者 ford pickup part : January 28, 2007 03:40 AM
Cool site. Thank you!
http://gastricbypasssurgery-61257s.kozlyonok.info/ gastricbypasssurgery
投稿者 gastricbypasssurgery : January 28, 2007 03:58 PM
Nice site. Thank you!!!
http://mailhandlers-com-61257s.loshad.info/ mailhandlers.com
投稿者 mailhandlers.com : January 29, 2007 08:24 PM
Very good site. Thanks!!!
http://distributor-lead-mlm-61257s.svinka.info/ distributor lead mlm
投稿者 distributor lead mlm : January 29, 2007 09:36 PM
Very good site. Thanks!!!
http://distributor-lead-mlm-61257s.svinka.info/ distributor lead mlm
投稿者 distributor lead mlm : January 29, 2007 09:36 PM
Cool site. Thanks!!!
http://gamesbyemail-61257s.kotyonok.info/ gamesbyemail
投稿者 gamesbyemail : January 29, 2007 10:41 PM
Cool site. Thanks!!!
http://gamesbyemail-61257s.kotyonok.info/ gamesbyemail
投稿者 gamesbyemail : January 29, 2007 10:42 PM
Then Bacon was a lugger.
投稿者 george ministeri s psychic links : January 31, 2007 02:20 AM
They said what I am to meet them, as the riven hickory when it is all Huron!
投稿者 laguna beach tides inn reviews : February 6, 2007 12:01 AM
Cool site. Thank you.
http://communications.articles-rich.com/mobile-phones
投稿者 Anonymous : February 9, 2007 09:28 PM
Cool site. Thank you.
http://communications.articles-rich.com/mobile-phones
投稿者 Anonymous : February 9, 2007 09:29 PM
Cool site. Thanks!
http://communications.articles-rich.com/voip
投稿者 Anonymous : February 9, 2007 10:48 PM
Nice site. Thank you.
http://business.articles-rich.com/advertising/
投稿者 Anonymous : February 10, 2007 01:24 AM
Cool site. Thanks!
http://business.articles-rich.com/busines-branding
投稿者 Anonymous : February 10, 2007 03:17 AM
Good site. Thanks!!!
http://business.articles-rich.com/business-cleaning
投稿者 Anonymous : February 10, 2007 05:12 AM
Cool site. Thanks.
http://business.articles-rich.com/
投稿者 Anonymous : February 10, 2007 06:20 AM
Cool site. Thanks.
http://business.articles-rich.com/
投稿者 Anonymous : February 10, 2007 06:20 AM
Cool site. Thank you!
http://yandex.poolw4.info/index.html ford-pickup
投稿者 ford-pickup : February 10, 2007 10:12 AM
Cool site. Thank you:-)
http://msn.poolw4.info/index.html ford-pickup
投稿者 ford-pickup : February 10, 2007 04:36 PM
Cool site. Thanks!
http://mygooogle.host-page.com/ tramadol
投稿者 tramadol : February 12, 2007 07:10 AM
Cool site. Thanks:-)
http://mygooogle.host-page.com/ viagra
投稿者 viagra : February 12, 2007 08:56 AM
Cool site. Thanks:-)
http://mygooogle.host-page.com/ viagra
投稿者 viagra : February 12, 2007 08:56 AM
Good site. Thanks.
http://mygooogle.host-page.com/ viagra
投稿者 viagra : February 12, 2007 04:08 PM
Nice site. Thank you!!!
http://mygooogle.host-page.com/ xanax
投稿者 xanax : February 12, 2007 07:02 PM
Nice site. Thank you!!!
http://mygooogle.host-page.com/ xanax
投稿者 xanax : February 12, 2007 07:02 PM
Cool site. Thank you.
http://mygooogle.host-page.com/ tramadol
投稿者 tramadol : February 12, 2007 09:35 PM
Cool site. Thank you.
http://mygooogle.host-page.com/ tramadol
投稿者 tramadol : February 12, 2007 09:36 PM
Nice site. Thanks:-)
http://mygooogle.host-page.com/ viagra
投稿者 viagra : February 12, 2007 11:15 PM
Nice site. Thanks:-)
http://mygooogle.host-page.com/ viagra
投稿者 viagra : February 12, 2007 11:15 PM
Very good site. Thanks!!!
http://mygooogle.host-page.com/ xanax
投稿者 xanax : February 13, 2007 05:11 AM
Cool site. Thank you!
http://bank.mygooogle.info/map.html bank america home equity loan rate
投稿者 bank america home equity loan rate : February 14, 2007 06:29 AM
Nice site. Thank you.
http://casino.mygooogle.info/ casino best game
投稿者 casino best game : February 27, 2007 04:51 PM
Nice site. Thank you.
http://casino.mygooogle.info/ casino best game
投稿者 casino best game : February 27, 2007 04:51 PM
Nice site. Thank you.
http://mygooogle.host-page.com tramadol
投稿者 tramadol : February 27, 2007 07:00 PM
Nice site. Thank you.
http://mygooogle.host-page.com tramadol
投稿者 tramadol : February 27, 2007 07:00 PM
Very good site. Thanks!!!
http://mjuhy.zor.org casino
投稿者 casino : March 11, 2007 10:09 PM
Nice site. Thank you:-)
http://http://casino.digs.it/ casino online
投稿者 casino online : March 12, 2007 12:38 AM
Cool site. Thank you.
http://casinoeuro.kickme.to/ casino
投稿者 casino : March 12, 2007 05:24 AM
Good site. Thank you!!!
http://schools.kz.cx/ schools
投稿者 schools : March 12, 2007 06:39 AM
Good site. Thank you!!!
http://schools.kz.cx/ schools
投稿者 schools : March 12, 2007 06:40 AM
Very good site. Thanks!
http://idea.mygooogle.info/ online school counseling degree
投稿者 online school counseling degree : March 12, 2007 09:41 AM
Very good site. Thanks!
http://idea.mygooogle.info/ online school counseling degree
投稿者 online school counseling degree : March 12, 2007 09:41 AM
Cool site. Thanks.
http://debug.orgfree.com viagra tramadol
投稿者 viagra tramadol : March 12, 2007 11:57 AM
Cool site. Thanks.
http://debug.orgfree.com viagra tramadol
投稿者 viagra tramadol : March 12, 2007 11:58 AM
Good site. Thanks!!!
http://777.orgfree.com online casino
投稿者 online casino : March 12, 2007 04:09 PM
Good site. Thanks:-)
http://1.keris.tu1.ru
投稿者 Anonymous : March 12, 2007 09:25 PM
Good site. Thanks:-)
http://1.keris.tu1.ru
投稿者 Anonymous : March 12, 2007 09:25 PM
Cool site. Thanks:-)
http://www.geocities.com/chanceyram5518/ viagra
投稿者 viagra : March 13, 2007 12:55 AM
Cool site. Thank you:-)
http://www.geocities.com/amigawei8362/ Propecia
投稿者 Propecia : March 13, 2007 02:11 AM
Very good site. Thanks:-)
http://www.geocities.com/geniamorgana6379/ mortgage
投稿者 mortgage : March 13, 2007 05:20 AM
Cool site. Thanks!
http://www.geocities.com/statlerhavel6056/ loan
投稿者 loan : March 13, 2007 08:12 AM
Very good site. Thank you.
http://www.geocities.com/winesapsnell8924/ bill o reilly
投稿者 bill o reilly : March 13, 2007 01:02 PM
Very good site. Thank you.
http://www.geocities.com/winesapsnell8924/ bill o reilly
投稿者 bill o reilly : March 13, 2007 01:03 PM
Very good site. Thank you.
http://www.geocities.com/winesapsnell8924/ bill o reilly
投稿者 bill o reilly : March 13, 2007 01:03 PM
Cool site. Thanks.
http://www.geocities.com/gloriconni5234/ casino online
投稿者 casino online : March 13, 2007 04:11 PM
Cool site. Thanks!
http://www.geocities.com/nevileliege0888/ casino online bonus
投稿者 casino online bonus : March 13, 2007 09:01 PM
Very good site. Thank you.
http://www.geocities.com/novgorodabeu3163/ online gambling
投稿者 online gambling : March 13, 2007 10:11 PM
Cool site. Thanks.
http://www.geocities.com/drudhomer5781/ casino free bonus $500
投稿者 casino free bonus $500 : March 14, 2007 12:18 AM
Nice site. Thanks!!!
http://www.geocities.com/leriverside5930/ CASINO
投稿者 CASINO : March 14, 2007 02:01 AM
Very good site. Thanks!!!
http://eliminatecreditcarddebt.110mb.com/ card debt
投稿者 card debt : March 14, 2007 07:05 AM
Very good site. Thanks!!!
http://eliminatecreditcarddebt.110mb.com/ card debt
投稿者 card debt : March 14, 2007 07:05 AM
Cool site. Thank you.
http://bestsearch.110mb.com credit card
投稿者 credit card : March 14, 2007 10:31 AM
Cool site. Thank you.
http://bestsearch.110mb.com credit card
投稿者 credit card : March 14, 2007 10:32 AM
Cool site. Thanks!!!
http://travelrewardcreditcard.110mb.com credit card
投稿者 credit card : March 14, 2007 03:33 PM
Very good site. Thank you!
http://washingtonmutualcreditcard.110mb.com card debt
投稿者 card debt : March 14, 2007 08:26 PM
Very good site. Thanks!
http://geocities.com/ryderdetroit3406/
投稿者 Anonymous : March 14, 2007 10:11 PM
Good site. Thank you.
http://www.geocities.com/taneyumeko6367/
投稿者 Anonymous : March 14, 2007 11:24 PM
Nice site. Thanks.
http://keris.teracities.com
投稿者 Anonymous : March 15, 2007 03:58 AM
Nice site. Thanks.
http://keris.teracities.com
投稿者 Anonymous : March 15, 2007 03:58 AM
Very good site. Thanks!
http://www.geocities.com/chanceyram5518/
投稿者 Anonymous : March 15, 2007 05:23 AM
Nice site. Thanks!!!
http://phillips-dbox.mygooogle.info/
投稿者 Anonymous : March 15, 2007 04:59 PM
Nice site. Thanks!!!
http://phillips-dbox.mygooogle.info/
投稿者 Anonymous : March 15, 2007 05:00 PM
Nice site. Thanks!!!
http://phillips-dbox.mygooogle.info/
投稿者 Anonymous : March 15, 2007 05:00 PM
Cool site. Thanks!!!
http://loan.mygooogle.info
投稿者 Anonymous : March 15, 2007 08:06 PM
Cool site. Thank you!
http://tiens-omsk.info
投稿者 Anonymous : March 15, 2007 09:24 PM
Nice site. Thank you.
http://search10site.info/
投稿者 Anonymous : March 15, 2007 10:48 PM
Nice site. Thank you.
http://search10site.info/
投稿者 Anonymous : March 15, 2007 10:49 PM
Cool site. Thank you:-)
http://gamingbest10.info
投稿者 Anonymous : March 16, 2007 02:44 AM
Cool site. Thank you:-)
http://gamingbest10.info
投稿者 Anonymous : March 16, 2007 02:44 AM
Cool site. Thanks!!!
http://golghyip777.ueuo.com hyip
投稿者 hyip : March 16, 2007 09:39 AM
Nice site. Thanks!
http://idea.mygooogle.info/ Online Schools
投稿者 Online Schools : March 16, 2007 12:11 PM
Good site. Thank you:-)
http://casino.mygooogle.info/ online casino
投稿者 online casino : March 16, 2007 02:21 PM
Nice!
投稿者 Hbvdcv : March 16, 2007 05:51 PM
Very good site. Thanks.
http://casino.mygooogle.info/ game online
投稿者 game online : March 17, 2007 01:33 AM
Very good site. Thanks.
http://casino.mygooogle.info/ game online
投稿者 game online : March 17, 2007 01:33 AM
Very good site. Thank you.
http://casino.mygooogle.info/
投稿者 Anonymous : March 17, 2007 07:32 AM
Nice site. Thank you!!!
http://casino.mygooogle.info/
投稿者 Anonymous : March 17, 2007 12:27 PM
Nice site. Thank you!!!
http://casino.mygooogle.info/
投稿者 Anonymous : March 17, 2007 12:27 PM
Very good site. Thank you:-)
http://casino.mygooogle.info/
投稿者 Anonymous : March 17, 2007 01:24 PM
Very good site. Thank you:-)
http://casino.mygooogle.info/
投稿者 Anonymous : March 17, 2007 01:24 PM
Cool site. Thanks:-)
http://idea.mygooogle.info/
投稿者 Anonymous : March 17, 2007 05:33 PM
Cool site. Thanks:-)
http://idea.mygooogle.info/
投稿者 Anonymous : March 17, 2007 05:33 PM
Very good site. Thank you:-)
http://casino.mygooogle.info/
投稿者 Anonymous : March 17, 2007 07:05 PM
Very good site. Thank you:-)
http://casino.mygooogle.info/
投稿者 Anonymous : March 17, 2007 07:05 PM
Very good site. Thank you!!!
http://golghyip777.ueuo.com
投稿者 Anonymous : March 17, 2007 08:16 PM
Very good site. Thanks!
http://travelusa.s4.ho.com.ua
投稿者 Anonymous : March 18, 2007 02:32 AM
Nice site. Thanks!!!
http://golghyip777.ueuo.com
投稿者 Anonymous : March 18, 2007 03:40 AM
Very good site. Thanks.
http://money.mygooogle.info/
投稿者 Anonymous : March 18, 2007 06:22 AM
Very good site. Thanks.
http://money.mygooogle.info/
投稿者 Anonymous : March 18, 2007 06:22 AM
Very good site. Thank you.
http://casino.mygooogle.info/
投稿者 Anonymous : March 18, 2007 09:52 AM
Very good site. Thank you!
http://idea.mygooogle.info/
投稿者 Anonymous : March 18, 2007 12:56 PM
Very good site. Thank you!
http://idea.mygooogle.info/
投稿者 Anonymous : March 18, 2007 12:57 PM
Good site. Thank you.
http://bank.mygooogle.info/57 bank of america
投稿者 bank of america : March 19, 2007 05:16 PM
Cool site. Thank you:-)
http://www.freehostinfo.150m.com/ golf club catalog
投稿者 golf club catalog : March 20, 2007 01:53 AM
Cool site. Thanks.
http://freeinfo.275mb.com
投稿者 Anonymous : March 20, 2007 03:03 PM
Cool site. Thanks.
http://freeinfo.275mb.com
投稿者 Anonymous : March 20, 2007 03:04 PM
Good site. Thank you!
http://www.freehostinfo.150m.com club golf
投稿者 club golf : March 20, 2007 06:47 PM
Good site. Thank you!
http://www.freehostinfo.150m.com club golf
投稿者 club golf : March 20, 2007 06:49 PM
Nice site. Thank you:-)
http://www.google.com/notebook/public/00357843427626116647/BDQsJQwoQrvGJ75Yi dreams lyrics allmans
投稿者 dreams lyrics allmans : March 20, 2007 08:01 PM
Nice site. Thank you:-)
http://www.google.com/notebook/public/00357843427626116647/BDQsJQwoQrvGJ75Yi dreams lyrics allmans
投稿者 dreams lyrics allmans : March 20, 2007 08:01 PM
Good site. Thank you.
http://arts-entertainment.articles-rich.com articles
投稿者 articles : March 21, 2007 12:11 AM
Cool site. Thank you:-)
http://www.travelusa.ho.com.ua/ bonus casino
投稿者 bonus casino : March 21, 2007 02:35 AM
Very good site. Thank you!
http://www.travelusa.ho.com.ua/ best rulette
投稿者 best rulette : March 21, 2007 01:03 PM
Nice site. Thank you!!!
http://www.freehostinfo.150m.com club best
投稿者 club best : March 21, 2007 02:12 PM
Nice site. Thank you.
http://onegold.freehp.info/sitemap.html egold
投稿者 egold : March 21, 2007 09:59 PM
Nice site. Thank you.
http://onegold.freehp.info/sitemap.html egold
投稿者 egold : March 21, 2007 09:59 PM
Cool site. Thanks!!!
http://arts-entertainment.articles-rich.com/map.html new articles
投稿者 new articles : March 22, 2007 01:28 AM
Cool site. Thanks!!!
http://arts-entertainment.articles-rich.com/map.html new articles
投稿者 new articles : March 22, 2007 01:28 AM
Cool site. Thank you!
http://www.freehostinfo.150m.com
投稿者 Anonymous : March 22, 2007 05:47 AM
Good site. Thanks.
www.phrae.mju.ac.th/test.asp
投稿者 Anonymous : March 22, 2007 05:16 PM
Cool site. Thanks!!!
http://freeinfo.275mb.com/ adsense
投稿者 adsense : March 22, 2007 06:38 PM
Very good site. Thanks!!!
http://tiens-omsk.info/news news
投稿者 news : March 22, 2007 07:47 PM
Very good site. Thanks!!!
http://tiens-omsk.info/news news
投稿者 news : March 22, 2007 07:47 PM
Cool site. Thank you!
http://arts-entertainment.articles-rich.com/map.html news
投稿者 news : March 22, 2007 10:35 PM
Good site. Thanks.
http://golghyip777.ueuo.com hyip egold
投稿者 hyip egold : March 23, 2007 03:05 PM
Nice site. Thanks!
http://mieluy.pochta.ru rielt
投稿者 rielt : March 23, 2007 04:20 PM
Nice site. Thank you!
http://mieloi.pochta.ru ru rielt
投稿者 ru rielt : March 23, 2007 05:29 PM
Very good site. Thank you!
http://mielqq.pochta.ru rus rielt
投稿者 rus rielt : March 23, 2007 08:01 PM
Good site. Thank you.
http://mielww.pochta.ru us rielt
投稿者 us rielt : March 23, 2007 10:18 PM
Very good site. Thanks!!!
http://mielee.front.ru doma net
投稿者 doma net : March 25, 2007 12:17 AM
Good site. Thanks.
http://miel77.front.ru vash dom
投稿者 vash dom : March 25, 2007 06:34 AM
Good site. Thanks.
http://miel77.front.ru vash dom
投稿者 vash dom : March 25, 2007 06:35 AM
Good site. Thanks!
http://viplady.pop3.ru
投稿者 Anonymous : March 25, 2007 06:25 PM
Good site. Thanks!
http://viplady.pop3.ru
投稿者 Anonymous : March 25, 2007 06:25 PM
Good site. Thank you:-)
http://eliteladyx.rbcmail.ru
投稿者 о : March 25, 2007 08:47 PM
Good site. Thanks:-)
http://bankofamerica.huip.info bankofamerica
投稿者 banking : March 26, 2007 10:10 PM
Nice site. Thanks!
http://google.huip.info free porn
投稿者 porn : March 26, 2007 11:36 PM
Nice site. Thanks!
http://google.huip.info free porn
投稿者 porn : March 26, 2007 11:36 PM
Very good site. Thank you!!!
http://msn.huip.info forex-forecast
投稿者 forex : March 27, 2007 12:49 AM
Nice site. Thank you!!!
http://golf.us-msn.com/ golf club
投稿者 golf pages : March 27, 2007 05:39 PM
Nice site. Thank you!!!
http://golf.us-msn.com/ golf club
投稿者 golf pages : March 27, 2007 05:39 PM
Cool site. Thanks:-)
http://buyauto.uzgate.com sex movies
投稿者 sex : March 27, 2007 10:47 PM
Cool site. Thanks:-)
http://buyauto.uzgate.com sex movies
投稿者 sex : March 27, 2007 10:47 PM
The popular hair-growth drug finasteride, taken by millions of balding men, artificially lowers the results of the prostate-specific antigen (PSA) test, the standard screening test for prostate cancer, a multicenter study has found.
The study, involving 308 men ranging in age from 40 to 60 years old, is available online in the British medical journal The Lancet and is scheduled to be published after Jan. 1, 2007. The study calls for new clinical guidelines for primary-care physicians, dermatologists and urologists to account for the role of finasteride, known as Propecia when used for hair loss, while evaluating PSA results.
"It's not universally known that finasteride lowers PSA levels in younger men who take it for hair growth," said Dr. Claus Roehrborn, chairman of urology at UT Southwestern Medical Center and co-principal investigator of The Lancet study, along with Dr. Anthony D'Amico of Brigham and Women's Hospital and Dana-Farber Cancer Institute in Boston. "It is important for physicians to know that many young men take Propecia and that their PSA level is lowered artificially. Doctors need to adjust the PSA interpretation by multiplying it times two for these men."
Finasteride was initially developed in the 1990s for the treatment of benign prostatic hyperplasia (BPH), better known as enlarged-prostate disease, and was first approved by the U.S. Food and Drug Administration for this use. Patients with BPH must strain to pass urine and feel the urge to urinate frequently. BPH can lead to the inability to urinate and urinary tract infection.
In 1997 the FDA approved finasteride for the treatment of male-pattern baldness. While Propecia is administered at 1 milligram per day, patients who take the finasteride drug Proscar for BPH get a five times higher dosage, 5 mg per day.
"The impact of finasteride on PSA levels is significant," said Dr. Roehrborn. "This needs to be realized by all internists, family-care doctors, dermatologists - anybody who writes prescriptions for male-pattern hair loss."
Researchers have known for years that the same testosterone metabolism responsible for prostate growth also causes male-pattern baldness (called androgenic alopecia), Dr. Roehrborn said. Both BPH and male-pattern hair loss have to do with the male hormone testosterone, which is being converted to dihydrotestosterone (DHT) by an enzyme named 5-alpha reductase. DHT activates the genes responsible for the development of male-pattern hair loss. Finasteride interferes with this process by blocking 5-alpha reductase and preventing the conversion of testosterone to DHT.
The data in The Lancet study were collected by Dr. Roehrborn from 1998 to 2000 in cooperation with medical centers in Arizona, Colorado, Connecticut, Georgia, Indiana, Louisiana, Minnesota, New York, North Carolina, Oregon, Texas and Virginia.
The data in The Lancet study are derived from a study Dr. Roehrborn conducted with Merck & Co., Inc. in 2000. Dr. Roehrborn, discussing the reasons to publish this report now, said: "The data are published now out of recognition that there was an acknowledged gap in the primary-care community about the impact of Propecia on PSA levels. When doctors ask for their patients' medical history, they need to ask if they have taken any drugs for hair loss, and the doctors need to multiply the PSA readings by two."
The current study also was funded by Merck & Co., Inc.
About UT Southwestern Medical Center
UT Southwestern Medical Center, one of the premier medical centers in the nation, integrates pioneering biomedical research with exceptional clinical care and education. Its more than 1,400 full-time faculty members - including four active Nobel Prize winners, more than any other medical school in the world - are responsible for groundbreaking medical advances and are committed to translating science-driven research quickly to new clinical treatments. UT Southwestern physicians provide medical care in 40 specialties to nearly 89,000 hospitalized patients and oversee 2.1 million outpatient visits a year.
UT Southwestern Medical Center
United States
cheap propecia usa
投稿者 HarryHines : April 16, 2007 02:06 PM
The popular hair-growth drug finasteride, taken by millions of balding men, artificially lowers the results of the prostate-specific antigen (PSA) test, the standard screening test for prostate cancer, a multicenter study has found.
The study, involving 308 men ranging in age from 40 to 60 years old, is available online in the British medical journal The Lancet and is scheduled to be published after Jan. 1, 2007. The study calls for new clinical guidelines for primary-care physicians, dermatologists and urologists to account for the role of finasteride, known as Propecia when used for hair loss, while evaluating PSA results.
"It's not universally known that finasteride lowers PSA levels in younger men who take it for hair growth," said Dr. Claus Roehrborn, chairman of urology at UT Southwestern Medical Center and co-principal investigator of The Lancet study, along with Dr. Anthony D'Amico of Brigham and Women's Hospital and Dana-Farber Cancer Institute in Boston. "It is important for physicians to know that many young men take Propecia and that their PSA level is lowered artificially. Doctors need to adjust the PSA interpretation by multiplying it times two for these men."
Finasteride was initially developed in the 1990s for the treatment of benign prostatic hyperplasia (BPH), better known as enlarged-prostate disease, and was first approved by the U.S. Food and Drug Administration for this use. Patients with BPH must strain to pass urine and feel the urge to urinate frequently. BPH can lead to the inability to urinate and urinary tract infection.
In 1997 the FDA approved finasteride for the treatment of male-pattern baldness. While Propecia is administered at 1 milligram per day, patients who take the finasteride drug Proscar for BPH get a five times higher dosage, 5 mg per day.
"The impact of finasteride on PSA levels is significant," said Dr. Roehrborn. "This needs to be realized by all internists, family-care doctors, dermatologists - anybody who writes prescriptions for male-pattern hair loss."
Researchers have known for years that the same testosterone metabolism responsible for prostate growth also causes male-pattern baldness (called androgenic alopecia), Dr. Roehrborn said. Both BPH and male-pattern hair loss have to do with the male hormone testosterone, which is being converted to dihydrotestosterone (DHT) by an enzyme named 5-alpha reductase. DHT activates the genes responsible for the development of male-pattern hair loss. Finasteride interferes with this process by blocking 5-alpha reductase and preventing the conversion of testosterone to DHT.
The data in The Lancet study were collected by Dr. Roehrborn from 1998 to 2000 in cooperation with medical centers in Arizona, Colorado, Connecticut, Georgia, Indiana, Louisiana, Minnesota, New York, North Carolina, Oregon, Texas and Virginia.
The data in The Lancet study are derived from a study Dr. Roehrborn conducted with Merck & Co., Inc. in 2000. Dr. Roehrborn, discussing the reasons to publish this report now, said: "The data are published now out of recognition that there was an acknowledged gap in the primary-care community about the impact of Propecia on PSA levels. When doctors ask for their patients' medical history, they need to ask if they have taken any drugs for hair loss, and the doctors need to multiply the PSA readings by two."
The current study also was funded by Merck & Co., Inc.
About UT Southwestern Medical Center
UT Southwestern Medical Center, one of the premier medical centers in the nation, integrates pioneering biomedical research with exceptional clinical care and education. Its more than 1,400 full-time faculty members - including four active Nobel Prize winners, more than any other medical school in the world - are responsible for groundbreaking medical advances and are committed to translating science-driven research quickly to new clinical treatments. UT Southwestern physicians provide medical care in 40 specialties to nearly 89,000 hospitalized patients and oversee 2.1 million outpatient visits a year.
UT Southwestern Medical Center
United States
cheap propecia usa
投稿者 HarryHines : April 17, 2007 12:57 AM
Good site. Thank you:-)
http://xstarslady.pochtamt.ru 闔齏� �銜� 釶鉞
投稿者 闔齏� �銜� 釶鉞 : April 17, 2007 04:28 PM
Good site. Thank you:-)
http://xstarslady.pochtamt.ru 闔齏� �銜� 釶鉞
投稿者 闔齏� �銜� 釶鉞 : April 17, 2007 04:28 PM
Cool site. Thanks:-)
http://xxnotee.pochta.ru 闔齏� 痳譛�
投稿者 闔齏� 痳譛� : April 19, 2007 06:31 PM
Nice site. Thank you:-)
http://igraintim.smtp.ru 闔齏� 窶諷鞳� 髓黻纃鴈�
投稿者 闔齏� 窶諷鞳� 髓黻纃鴈� : April 26, 2007 08:23 AM
Good site! vicodin, ([url=http://vicodin_nah.iwannaforum.com]vicodin[/url]).
投稿者 vicodin : April 26, 2007 09:48 AM
Cool site. Thank you.
http://sex.mygooogle.info 闔齏� 謌驕�
投稿者 闔齏� 謌驕� : May 1, 2007 02:18 PM
Nice site. Thanks:-)
http://onegold.huip.info 闔齏� 騾蜥� 鴈跣袱
投稿者 闔齏� 騾蜥� 鴈跣袱 : May 2, 2007 12:51 PM
All a tara reid sex little girl as the hand was into. Yeah, tara reid naked remaining seated on the singer's eyes should have been. She could feel. You. Alison turned tara reid porn towards her legs apart like that dildo. tara reid body shots Susan looked up so everyone can. Her eyes. Slowly the verge of her breasts had to tell tara reid nude for an.
投稿者 tarasex : May 6, 2007 12:20 AM
Cool site. Thanks!
http://ass.mygooogle.info google
投稿者 google : May 6, 2007 06:35 PM
Cool site. Thanks!
http://ass.mygooogle.info google
投稿者 google : May 6, 2007 06:36 PM
Nice site. Thanks!!!
http://casino.mygooogle.info google
投稿者 google : May 6, 2007 10:12 PM
Cool site. Thank you!!!
http://idea.mygooogle.info google
投稿者 google : May 6, 2007 11:27 PM
Cool site. Thank you!!!
http://idea.mygooogle.info google
投稿者 google : May 6, 2007 11:28 PM
Good site. Thanks:-)
http://insurance.mygooogle.info google
投稿者 google : May 7, 2007 12:41 AM
Good site. Thanks!!!
http://loan.mygooogle.info google
投稿者 google : May 7, 2007 01:45 AM
Good site. Thanks:-)
http://money.mygooogle.info google
投稿者 google : May 7, 2007 04:37 AM
Good site. Thanks:-)
http://money.mygooogle.info google
投稿者 google : May 7, 2007 04:37 AM
Cool site. Thanks.
http://phillips-dbox.mygooogle.info google
投稿者 google : May 7, 2007 06:50 AM
Cool site. Thanks.
http://phillips-dbox.mygooogle.info google
投稿者 google : May 7, 2007 06:50 AM
Good site. Thanks:-)
http://search.mygooogle.info google
投稿者 google : May 7, 2007 09:39 AM
Very good site. Thank you:-)
http://sex.mygooogle.info google
投稿者 google : May 7, 2007 12:30 PM
Nice site. Thank you.
http://vip.mygooogle.info google
投稿者 google : May 7, 2007 02:24 PM
Good site. Thank you.
http://xxx.mygooogle.info google
投稿者 google : May 7, 2007 05:03 PM
On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug Propecia, prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).
投稿者 RobSeidman : May 9, 2007 07:43 AM
On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug Propecia, prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).
投稿者 RobSeidman : May 9, 2007 12:46 PM
On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug Propecia, prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).
投稿者 RobSeidman : May 9, 2007 06:06 PM
On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug Propecia, prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).
投稿者 RobSeidman : May 9, 2007 11:22 PM
On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug Propecia, prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).
投稿者 RobSeidman : May 10, 2007 03:25 PM
Nice site. Thank you!
http://pornosite.fromru.su SMS sex boy
投稿者 SMS sex boy : May 10, 2007 07:24 PM
On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug Propecia, prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).
投稿者 RobSeidman : May 10, 2007 09:48 PM
Good site. Thanks.
http://pornosite.hotbox.ru SMS sex boy
投稿者 SMS sex boy : May 10, 2007 10:20 PM
Cool site. Thanks:-)
http://pornosite.krovatka.su SMS sex boy
投稿者 SMS sex boy : May 11, 2007 12:41 AM
Cool site. Thanks:-)
http://pornosite.krovatka.su SMS sex boy
投稿者 SMS sex boy : May 11, 2007 12:41 AM
Very good site. Thanks!!!
http://yandexmail.rbcmail.ru SMS sex boy
投稿者 SMS sex boy : May 11, 2007 01:57 AM
Very good site. Thanks!!!
http://yandexmail.rbcmail.ru SMS sex boy
投稿者 SMS sex boy : May 11, 2007 01:58 AM
Nice site. Thanks:-)
http://yandexmail.fromru.su SMS sex boy
投稿者 SMS sex boy : May 11, 2007 03:29 AM
Nice site. Thanks:-)
http://yandexmail.fromru.su SMS sex boy
投稿者 SMS sex boy : May 11, 2007 03:29 AM
Nice site. Thanks:-)
http://yandexmail.fromru.su SMS sex boy
投稿者 SMS sex boy : May 11, 2007 03:30 AM
Nice site. Thanks!
http://pornosite.mail15.su SMS sex boy
投稿者 SMS sex boy : May 11, 2007 05:37 AM
Nice site. Thanks!
http://pornosite.mail15.su SMS sex boy
投稿者 SMS sex boy : May 11, 2007 05:37 AM
Nice site. Thank you!!!
http://pornosite.mail333.su SMS sex boy
投稿者 SMS sex boy : May 11, 2007 07:07 AM
Nice site. Thank you!!!
http://pornosite.mail333.su SMS sex boy
投稿者 SMS sex boy : May 11, 2007 07:08 AM
Cool site. Thanks!!!
http://vivatporn.front.ru SMS sex boy
投稿者 SMS sex boy : May 11, 2007 01:59 PM
Cool site. Thanks!!!
http://vivatporn.front.ru SMS sex boy
投稿者 SMS sex boy : May 11, 2007 01:59 PM
Nice site. Thanks.
http://vivatporn.hotbox.ru SMS sex boy
投稿者 SMS sex boy : May 11, 2007 03:08 PM
Cool site. Thanks:-)
http://vivatporn.pochtamt.ru SMS sex boy
投稿者 SMS sex boy : May 11, 2007 10:49 PM
Cool site. Thanks:-)
http://vivatporn.pochtamt.ru SMS sex boy
投稿者 SMS sex boy : May 11, 2007 10:49 PM
On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug Propecia, prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).
投稿者 RobSeidman : May 12, 2007 12:10 AM
Cool site. Thanks:-)
http://vivatporn.rbcmail.ru SMS sex boy
投稿者 SMS sex boy : May 12, 2007 02:58 AM
Very good site. Thank you:-)
http://higporn.front.ru SMS sex boy
投稿者 SMS sex boy : May 12, 2007 09:36 AM
Very good site. Thanks.
http://higporn.pochtamt.ru SMS sex boy
投稿者 SMS sex boy : May 12, 2007 02:35 PM
Very good site. Thanks.
http://higporn.pochtamt.ru SMS sex boy
投稿者 SMS sex boy : May 12, 2007 02:36 PM
On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug Propecia, prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).
投稿者 RobSeidman : May 12, 2007 03:09 PM
Cool site. Thanks!
http://higporn.pop3.ru SMS sex boy
投稿者 SMS sex boy : May 12, 2007 04:30 PM
Cool site. Thanks!
http://higporn.pop3.ru SMS sex boy
投稿者 SMS sex boy : May 12, 2007 04:33 PM
Nice site. Thank you!
http://higporn.smtp.ru SMS sex boy
投稿者 SMS sex boy : May 12, 2007 07:39 PM
On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug Propecia, prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).
投稿者 RobSeidman : May 12, 2007 08:23 PM
Good site. Thanks.
http://higporn1.land.ru SMS sex boy
投稿者 SMS sex boy : May 13, 2007 05:54 AM
On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug Propecia, prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).
投稿者 RobSeidman : May 13, 2007 06:42 AM
Cool site. Thank you!
http://higporn1.pochtamt.ru SMS sex boy
投稿者 SMS sex boy : May 13, 2007 07:49 AM
Cool site. Thank you!
http://higporn1.pochtamt.ru SMS sex boy
投稿者 SMS sex boy : May 13, 2007 07:49 AM
Good site. Thank you!!!
http://higporn.pisem.su SMS sex boy
投稿者 SMS sex boy : May 13, 2007 08:50 AM
Cool site. Thank you:-)
http://nudeporn.front.ru SMS sex boy
投稿者 SMS sex boy : May 13, 2007 09:53 AM
Cool site. Thanks:-)
http://nudeporn.hotbox.ru SMS sex boy
投稿者 SMS sex boy : May 13, 2007 11:39 AM
Cool site. Thanks:-)
http://nudeporn.hotbox.ru SMS sex boy
投稿者 SMS sex boy : May 13, 2007 11:39 AM
On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug Propecia, prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).
投稿者 RobSeidman : May 13, 2007 05:11 PM
Very good site. Thanks.
http://nudeporn.rbcmail.ru SMS sex boy
投稿者 SMS sex boy : May 13, 2007 05:49 PM
Very good site. Thanks.
http://nudeporn.rbcmail.ru SMS sex boy
投稿者 SMS sex boy : May 13, 2007 05:49 PM
Cool site. Thanks!
http://nudeporn.smtp.ru SMS sex boy
投稿者 SMS sex boy : May 13, 2007 07:20 PM
Cool site. Thanks!
http://nudeporn.smtp.ru SMS sex boy
投稿者 SMS sex boy : May 13, 2007 07:20 PM
Nice site. Thanks:-)
http://sukaporn.hotbox.ru SMS sex boy
投稿者 SMS sex boy : May 13, 2007 10:51 PM
Good site. Thanks!
http://sukaporn.land.ru SMS sex boy
投稿者 SMS sex boy : May 14, 2007 05:16 AM
Very good site. Thank you!!!
http://sukaporn.pochtamt.ru SMS sex boy
投稿者 SMS sex boy : May 14, 2007 08:15 AM
Nice site. Thanks!!!
http://sukaporn.pop3.ru SMS sex boy
投稿者 SMS sex boy : May 14, 2007 10:00 AM
Cool site. Thank you:-)
http://sukaporn.smtp.ru SMS sex boy
投稿者 SMS sex boy : May 14, 2007 01:56 PM
Very good site. Thanks!
http://xxx-moves.info н
投稿者 о : May 14, 2007 03:28 PM
Very good site. Thanks!
http://xxx-moves.info н
投稿者 о : May 14, 2007 03:29 PM
On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug Propecia, prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).
投稿者 RobSeidman : May 19, 2007 02:56 AM
On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug Propecia, prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).
投稿者 RobSeidman : May 24, 2007 07:52 AM
Good site. Thanks:-)
http://perfect-guyz.info/ guy porn video
投稿者 guy porn video : May 25, 2007 01:37 AM
On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug Propecia, prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).
投稿者 RobSeidman : May 25, 2007 10:46 PM
On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug Propecia, prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).
投稿者 RobSeidman : May 26, 2007 03:19 AM
She welcomed thong girls the little vee where my free hand and a day, he.
投稿者 ypebbazib : May 26, 2007 11:00 AM
On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug Propecia, prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).
投稿者 RobSeidman : May 26, 2007 07:22 PM
Cool site. Thank you.
http://perfect-guyz.info/ й
投稿者 с : May 26, 2007 11:22 PM
Cool site. Thank you.
http://perfect-guyz.info/ й
投稿者 с : May 26, 2007 11:23 PM
On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug Propecia, prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).
投稿者 RobSeidman : May 27, 2007 12:21 AM
On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug Propecia, prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).
投稿者 RobSeidman : May 27, 2007 11:18 AM
On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug Propecia, prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).
投稿者 RobSeidman : May 27, 2007 09:28 PM
On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug Propecia, prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).
投稿者 RobSeidman : May 28, 2007 02:40 AM
On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug Propecia, prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).
投稿者 RobSeidman : May 28, 2007 07:57 AM
On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug Propecia, prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).
投稿者 RobSeidman : May 28, 2007 01:13 PM
On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug Propecia, prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).
投稿者 RobSeidman : May 28, 2007 06:17 PM
She glanced at the strand cock in pussy of the double.
投稿者 ltekyvpygyk : May 29, 2007 12:55 PM
We rode white booty the sound of my ass. While.
投稿者 hhazxyqr : May 29, 2007 06:03 PM
Nice site. Thanks.
http://sextop.fromru.su р
投稿者 р : May 30, 2007 05:10 PM
Cool site. Thank you!!!
http://sextop.front.ru е
投稿者 в : May 30, 2007 06:45 PM
Good site. Thank you.
http://sextop.hotbox.ru ю
投稿者 о : May 30, 2007 10:17 PM
Good site. Thanks!!!
http://sextop.krovatka.su м
投稿者 т : May 31, 2007 04:59 AM
Good site. Thanks!!!
http://sextop.krovatka.su м
投稿者 т : May 31, 2007 05:00 AM
Cool site. Thank you!!!
http://sextop.land.ru о
投稿者 д : May 31, 2007 08:04 AM
But he'd sent as emily hot breast and amateurs gone wild spoon. Junior knelt over jakob's naked.
投稿者 zuhoqgus : May 31, 2007 09:10 AM
Good site. Thank you:-)
http://sextop.pop3.ru р
投稿者 р : May 31, 2007 08:03 PM
Very good site. Thanks.
http://sextop.rbcmail.ru и
投稿者 о : June 1, 2007 12:43 AM
Cool site. Thanks:-)
http://sextop.smtp.ru о
投稿者 о : June 1, 2007 04:43 AM
Cool site. Thanks.
http://mygay.pochta.ru н
投稿者 Anonymous : June 1, 2007 06:38 AM
The popular hair-growth drug finasteride, taken by millions of balding men, artificially lowers the results of the prostate-specific antigen (PSA) test, the standard screening test for prostate cancer, a multicenter study has found.
The study, involving 308 men ranging in age from 40 to 60 years old, is available online in the British medical journal The Lancet and is scheduled to be published after Jan. 1, 2007. The study calls for new clinical guidelines for primary-care physicians, dermatologists and urologists to account for the role of finasteride, known as Propecia when used for hair loss, while evaluating PSA results.
"It's not universally known that finasteride lowers PSA levels in younger men who take it for hair growth," said Dr. Claus Roehrborn, chairman of urology at UT Southwestern Medical Center and co-principal investigator of The Lancet study, along with Dr. Anthony D'Amico of Brigham and Women's Hospital and Dana-Farber Cancer Institute in Boston. "It is important for physicians to know that many young men take Propecia and that their PSA level is lowered artificially. Doctors need to adjust the PSA interpretation by multiplying it times two for these men."
Finasteride was initially developed in the 1990s for the treatment of benign prostatic hyperplasia (BPH), better known as enlarged-prostate disease, and was first approved by the U.S. Food and Drug Administration for this use. Patients with BPH must strain to pass urine and feel the urge to urinate frequently. BPH can lead to the inability to urinate and urinary tract infection.
In 1997 the FDA approved finasteride for the treatment of male-pattern baldness. While Propecia is administered at 1 milligram per day, patients who take the finasteride drug Proscar for BPH get a five times higher dosage, 5 mg per day.
"The impact of finasteride on PSA levels is significant," said Dr. Roehrborn. "This needs to be realized by all internists, family-care doctors, dermatologists - anybody who writes prescriptions for male-pattern hair loss."
Researchers have known for years that the same testosterone metabolism responsible for prostate growth also causes male-pattern baldness (called androgenic alopecia), Dr. Roehrborn said. Both BPH and male-pattern hair loss have to do with the male hormone testosterone, which is being converted to dihydrotestosterone (DHT) by an enzyme named 5-alpha reductase. DHT activates the genes responsible for the development of male-pattern hair loss. Finasteride interferes with this process by blocking 5-alpha reductase and preventing the conversion of testosterone to DHT.
The data in The Lancet study were collected by Dr. Roehrborn from 1998 to 2000 in cooperation with medical centers in Arizona, Colorado, Connecticut, Georgia, Indiana, Louisiana, Minnesota, New York, North Carolina, Oregon, Texas and Virginia.
The data in The Lancet study are derived from a study Dr. Roehrborn conducted with Merck & Co., Inc. in 2000. Dr. Roehrborn, discussing the reasons to publish this report now, said: "The data are published now out of recognition that there was an acknowledged gap in the primary-care community about the impact of Propecia on PSA levels. When doctors ask for their patients' medical history, they need to a